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Background: Comprehensive rehabilitation, involving health professionals from various disciplines, is widely used
as an adjunct to pharmacological and surgical treatment in people with rheumatic diseases. However, the evidence
for the clinical- and cost-effectiveness of such interventions is limited, and the majority of those who receive rehabilitation
are back to their initial health status six to 12 months after discharge.
Methods/design: To evaluate the goal attainment, health effects and cost-effectiveness of a new rehabilitation
programme compared to current traditional rehabilitation programmes for people with rheumatic diseases,
a stepped-wedge cluster randomized trial will be performed. Patients admitted for rehabilitation at six centres
in the south-eastern part of Norway will be invited to participate. In the trial, six participating centres will switch
from a control (current rehabilitation programme) to an intervention phase (the new rehabilitation programme)
in a randomized order. Supported by recent research, the new programme will be a supplement to the existing
programme at each centre, and will comprise four elements designed to enhance and support lifestyle changes
introduced in the rehabilitation period: structured goal-planning, motivational interviewing, a self-help booklet
and four follow-up telephone calls during the first five months following discharge. The primary outcome will
be health-related quality of life and goal attainment, as measured by the Patient Generated Index directly
before and after the rehabilitation stay, as well as after six and 12 months. Secondary outcomes will include
self-reported pain, fatigue, a global assessment of disease activity and motivation for change (measured on
11-point numeric ratings scales), health-related quality of life as measured by the Short Form 36 Health Survey
(SF-36) and utility assessed by the SF6D utility index.
The main analysis will be on an intention to treat basis and will assess the clinical- and cost-effectiveness of the
structured goal planning and tailored follow-up rehabilitation programme for patients with rheumatic diseases.
Discussion: The findings will constitute an important contribution to more cost-effective- and evidence-based
rehabilitation services for people with rheumatic diseases.
Trial registration: ISRCTN91433175.
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Inflammatory rheumatic diseases are characterized by
inflammatory processes that may lead to joint damage
and various degrees of disability, thus representing a major
burden to the individual patient and society. Current treat-
ment focuses on early diagnosis and early use of disease
modifying agents. Nevertheless, a major percentage of pa-
tients has a residual disability and will need some form of
rehabilitation throughout their life [1].
Rehabilitation has been defined by the World Health
Organization as “a process aimed at enabling people
with disabilities to reach and maintain their optimal
physical, sensory, intellectual, psychological and social
functional levels. Rehabilitation provides disabled people
with the tools they need to attain independence and self-
determination” [2].
As such, the rehabilitation process involves several pro-
fessions and services, and is characterized by being tailored
to the patients’ individual needs and challenges, with the
aim of reducing the consequences of illness while improv-
ing activity, participation and quality of life [3].
Several studies have shown that patients with rheum-
atic diseases benefit from rehabilitation. However, the ef-
fect seems to fade over time, and most patients are back
to their initial health status six to 12 months after dis-
charge [4-7]. A major challenge is therefore to help pa-
tients maintain self-management strategies introduced in
the rehabilitation period, thereby enhancing a longer
lasting effect of rehabilitation.
Goal planning is considered as an essential part of re-
habilitation practice and is a process directed at setting
goals at various levels of function, within different life
areas and in various time frames [8]. The key compo-
nents of goal setting are comprised of goal identification
and negotiation, action planning and appraisal and feed-
back of performance [9,10], and individualized weekly
action plans and participant handbooks are recom-
mended to enhance participants’ adherence and progress
towards long-term goals [11]. Even though research con-
cerning the effectiveness of goal planning in clinical re-
habilitation is scarce, the conclusions in a systematic
review by Levack et al. are that there is some, though
limited, evidence that goal planning can influence pa-
tient adherence to treatment regimes, as well as strong
evidence that specific, challenging goals can improve im-
mediate patient performance in some specific clinical
contexts [3]. In addition to having a potential for enhan-
cing the individual effect of rehabilitation, knowledge
about the content of rehabilitation goals in larger patient
groups is important to help ensure the delivery of rele-
vant rehabilitation interventions. Although there are
some studies that have explored rehabilitation goals in
other patient groups [12-15], little is known about re-
habilitation goals in people with rheumatic diseases.The objective of goal setting involves a change in patient
behaviour. Hence, theories of behaviour and behavioural
change may guide goal-setting interventions [16-18], and
several reviews conclude that the use of cognitive behav-
ioural approaches in exercise programmes and other self-
management interventions increase their effectiveness in
people with rheumatic diseases [11,19-21]. Reviews have
further demonstrated that motivational interviewing (MI) is
an effective approach towards changing behaviour [22-26].
MI is a client-centred information and motivation strategy
based on cognitive behavioural theory and the trans-
theoretical model [27,28]. It is designed to engage ambiva-
lent or resistant clients in the process of health behaviour
change, and also provides health practitioners with a means
of tailoring their interventions to suit the patient’s degree of
readiness for change. The approach has been widely used
in various clinical conditions such as substance abuse, diet-
ary adherence and smoking cessation, and may be an effect-
ive strategy to also promote healthy lifestyle changes in
people with rheumatic diseases.
Rehabilitation often addresses health lifestyle changes in-
volving a process that takes a certain amount of time before
being settled in as a new habit. The process involves both
cognitive and behavioural elements that may by the end of
a rehabilitation stay still be unclear and fragile [29]. A
follow-up intervention may therefore provide psychological
and social support to individual patients, thus helping
them achieve individual rehabilitation goals, imple-
ment lifestyle changes and adhere to different treat-
ment recommendations. Three randomized controlled
trials (RCTs) have demonstrated that patients who re-
ceived telephone calls to support individualized goals
and action plans had an increased adherence to- and
effect of the programme [30-32]. However, to the best
of our knowledge, active support after patients have
been discharged and returned to their local communi-
ties is not yet a part of routine rehabilitation care in
Norway, which may to some extent explain why the
effect of rehabilitation fades within a few months.
The treatment and rehabilitation of complex chronic
conditions are often resource-intensive and expensive,
both for the individual patient and for society [33], with
musculoskeletal disease accounting for the largest propor-
tion of health- and social benefits payments in Norway
[34]. From a health economic perspective, a follow-up
intervention may be cost saving, as it may prevent exacer-
bations of the disease, reduce non-adherence to treatment
and intensify or prolong the initial treatment investment by
helping people cope with chronic illness and manage dis-
ease consequences. This may reduce the burden of illness,
restrict revisits to clinicians and reduce treatment costs,
prevent readmissions to hospitals or rehabilitation centres
and reduce the general health-care expenditures [35,36]. If
effective, follow-up interventions may both save costs and
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and rehabilitation [30-32].
The aims and research questions of this study
The main objective will be to evaluate goal attainment,
health effects and the cost-effectiveness of a new re-
habilitation programme (which includes structured goal
planning and tailored follow-up after discharge) com-
pared to current traditional rehabilitation programmes
(with no structured goal planning or tailored follow-up)
for patients with rheumatic diseases.
More specifically, our study will consider the following
research questions:
 What is the content of patients’ rehabilitation goals
throughout the rehabilitation and follow-up period,
and are the goals stable over time?
 Is the new rehabilitation programme more effective
with regard to goal attainment and an improved
health-related quality of life compared to traditional
rehabilitation programmes for patients with
rheumatic diseases?
 Which factors (personal, disease-related and
contextual) are associated with goal attainment and
an improved health-related quality of life during the
first year following rehabilitation?
 Which of the two programmes (rehabilitation with
structured goal planning and tailored follow-up after
discharge vs. traditional rehabilitation with no structured
goal planning and tailored follow-up) provides the
most cost-effective use of health-care resources?
Methods
Study development
The trial will be developed as part of the research
activity in a Norwegian regional rheumatology research
network in Health Region South-East during the period
from 2010–2012, and is funded by a grant from the
Regional Health Authority. The rehabilitation branch
in the network consists of three clinicians from the















Figure 1 The stepped wedge randomised controlled design. The inclu
White cells represent intervention periods and grey cells represent control
are recorded in head of the column.six local study coordinators from five departments of
rheumatology and one rehabilitation centre, respectively
(hereafter termed centres), in addition to three representa-
tives from the Norwegian Rheumatism Association.
The group is led by two researchers from the National
Advisory Unit on Rehabilitation in Rheumatology (KBH
and IK). From March 2011, a research coordinator also
works full-time in the project (GB). The group will meet
five times during 2010 and the spring of 2011 to develop
the trial, including the designing and piloting of the new
rehabilitation programme. Additionally, e-mail corres-
pondence, telephone meetings and separate meetings
with two of the patient representatives will be used to
exchange information and give feedback on protocol
and intervention material.
Study design
This will be a pragmatic, multicentre, stepped-wedge
cluster randomized controlled trial [37,38] in which par-
ticipants will be assessed at admission to- (baseline) and
discharge from a rehabilitation stay, and after six and
12 months (Trial registration: ISRCTN91433175).
In the trial, six participating centres (clusters) will
switch from the control- (the current rehabilitation
programme) to the intervention phase (a new rehabilita-
tion programme with structured goal planning and tai-
lored follow-up added to the existing programme) in a
randomized order (see Figure 1 for an outline of the
study design). All centres will start the trial simultan-
eously and act as controls until the point in time that
they are randomized to cross over from control to inter-
vention, and all centres will provide the new programme
by the end of the inclusion period.
The new programme will represent a supplement to
the existing rehabilitation programmes, and all patients
will, regardless of being included in the trial or not, re-
ceive the programme currently delivered at the different
participant institutions when they are admitted. How-
ever, patients admitted in the intervention phase who do
not participate in the trial will not receive a telephone









sion of participants will start August 21st 2011, and end June 30th 2012.
periods. Dates for switching from control period to intervention period
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A minimum of 312 participants will be included in the
period from August 21st 2011 to June 30th 2012 through
an invitation from health professionals at each partici-
pating centre on admission to the rehabilitation stay.
Those who are interested will be screened for eligibility,
and receive oral and written information about the
study, and to enrol, participants will have to give their
written informed consent.
People will be eligible if they are 18 years or older, are
admitted for rehabilitation at one of the six participating
centres, have a good understanding of the Norwegian
language and have one of the following inflammatory
rheumatic diagnoses: rheumatoid arthritis, psoriatic arth-
ritis, ankylosing spondylitis, systemic lupus erythematosus
and juvenile idiopathic arthritis. In addition, patients with
generalized osteoarthritis with an affection of the hip and/
or knee will be included. Each participant’s diagnosis will be
verified by a clinical examination by a physician at admis-
sion, according to the diagnostic criteria for each of the
specific diagnoses. The exclusion criteria will be cognitive
impairment, severe psychiatric disorder or being admitted
for rehabilitation after elective orthopaedic surgery.
Sample size calculations
The sample size and power calculations have been esti-
mated for the primary end point in this study by use of
the sum score of the Patient Generated Index (PGI) at
the six- and 12-month follow-ups. Based on results from
a previous study [39], it is estimated that a sample size
of six clusters at 80% power, with an average of 52 indi-
viduals per cluster (total of 312), will be needed to detect
a mean 10% difference (=10 points) between the groups
when the standard deviation is approximately 14 units in
the baseline PGI scores, the intra-cluster correlation is
0.3 and the drop-out rate is 20%.
Randomization and blinding
According to the stepped-wedge design, the intervention
will be sequentially rolled out at the participating centres
over a number of different time periods (see Figure 1 for
an outline of the study design). The order in which the
different centres will receive the intervention will be
determined at random by the study biostatistician (PM) by
using a computer-generated random numbers programme
(SAS). The randomisation procedure will take place in au-
gust 2010, and will be made known to the participating
centres at a workshop arranged immediately before starting
inclusion of participants. The randomisation group of each
participant will be determined by her/his admission date;
i.e. consenting patients admitted to a centre delivering the
control intervention will be included in the control group,
whereas patients admitted to a centre delivering the new
intervention will be included in the intervention group.As with most non-pharmacological treatments, it will
be impossible to carry out a double blind study because
the therapists will know which programme they will
deliver.
The new programme will represent a supplement
to- and an extension of the existing rehabilitation pro-
grammes, and all patients will, regardless of being in-
cluded in the trial or not, receive the programme
currently offered at the different participant institu-
tions. As opposed to other randomized controlled tri-
als in which participants are randomized into either a
treatment- or control group, we therefore believe that
this design may keep participants blinded for group
allocation.
The outcome data at the six- and 12-month follow up
will be collected in telephone interviews by a secretary
who is blinded for the allocation sequence.
Furthermore, the statistician who will perform the main
statistical analyses will be blinded to group allocation
during analyses.Training of intervention providers
Four workshops will be arranged in the data collection
period of the study to prepare and educate the providers
of the intervention at each centre, and the first work-
shop will be held before the start of the study with an
agenda comprising the following lectures and exercises:
 The theoretical basis of motivational interviewing
(MI);
 Exercises in how to practice MI in setting
rehabilitation goals;
 Using MI in telephone follow-up calls;
 Content and use of the self-management booklet;
 Logistics, routines for data collection and
management of data in the study;
 Exercises in how to invite and inform study
participants.
The second workshop will be held at each participating
centre a few weeks before the centre switches from the
control to the intervention period. Three persons from the
National Advisory Unit on Rehabilitation in Rheumatology
(TD, GB and IK) will visit the centre and give lectures and
training sessions in project organization, the methods of
data collection, privacy matters and MI.
Half-way through the data collection period, a third
workshop with all participating centres and intervention
providers, comprising more lectures and exercises in MI,
setting rehabilitation goals, telephone follow-up calls
and study logistics will be held. Additionally, providers
from the centres that have switched to the new rehabili-
tation programme will share their experiences, and there
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lated to relevant topics.
The last workshop will be arranged when all telephone
follow-up calls have been completed. The main aim of
this workshop will be to allow for feedback from inter-
vention providers to researchers and vice versa, and to
discuss ideas and methods for implementing the new
programme into clinical practice.
All local study coordinators, intervention providers
and representatives from the Norwegian Rheumatism
Association (NRA) will be invited to participate in the
first, third and fourth workshop, and the local study
coordinator and a local representative from the NRA
will be invited to participate at the workshops held at
each centre.
Interventions
Both groups will receive medical treatment as usual.
Control group
The control group will receive the traditional rehabilita-
tion programme provided at each participating centre at
the start of the study (see Table 1 for a brief description
of the programme at each centre). Directly following the
second (local) workshop, we will interview the local
study coordinator, using the STAR-ETIC rehabilitation
framework to structure the interview and capture the
context, structure, process and outcomes of the current
rehabilitation programme [40].
Intervention group
The intervention group will receive the new rehabilita-
tion programme, which will be based on the existing re-
habilitation programmes delivered at the participating
centres, but with four additional elements:
1. A self-management booklet for use both during and
after the rehabilitation stay;
2. A structured goal-setting process during the
rehabilitation stay, including goals with which the
patients will proceed in their home setting after
discharge;
3. A follow-up programme consisting of four phone
calls from a rehabilitation care provider at the
rehabilitation centre directed at goal attainment and
motivation for a continued effort;
4. Systematic use of motivational interviewing in
the goal-setting process and in the follow-up
phone calls.
Through the use of the following means, the aim of
the new programme will be to solve ambivalence,
increase self-efficacy, develop and maintain supportiveself-talk, prevent the fading of achieved outcome and
motivate for a continued effort by preventing relapse:
1. The self-management booklet: The booklet will
be a personal belonging for the participant to keep
and use both during and after the rehabilitation
stay. It will be given to the participant at admission
to the centre, and contain two main chapters. The
first chapter will address topics of relevance for
the rehabilitation stay such as “setting individual
rehabilitation goals”, “motivation for change”, “positive
self-talk”, “choosing what to pay attention to” and
“worth remembering”.
The second chapter will contain topics of relevance
for the first period after admission, starting with a
summary of the first chapter. Thereafter, the
headings will be as follows: “how to develop new
goals”, “a retrospective look at motivation”, “one
month after admission”, “three months after
admission” and “windup”.
Throughout the book there will be open questions
for the participant to answer, fields where he/she
can make personal notes, small exercises in, e.g.
mindfulness and relaxation, numeric rating scales
where one can rate, e.g. one’s self-efficacy related to
specific goals, quotes concerning rehabilitation goals,
motivation and strategies taken from qualitative
interviews with patients who have undergone
rehabilitation [41] and illustrative pictures and poems.
The following templates will follow in an appendix,
including a day- and week activity schedule, two
24-hour activity circles in which the participant can
fill in current and desired activity pattern and an
activity diary.
2. The goal-setting process: Patient-specific rehabili-
tation goals will be developed by the participant
together with one or more members from the
multidisciplinary team during an initial goal-setting
conversation, and will be used as a basis for tailoring
the rehabilitation interventions, while at the end of the
rehabilitation stay the participants will be asked to
evaluate their goals and choose the most important
goals to proceed with in their home setting (see out-
line of questions in Table 2). Moreover, a follow-up
support addressing strategies to achieve the individual
rehabilitation goals and maintain self-management
and adherence to health promoting behaviour will
be discussed, and appointments will be made for
the follow-up calls.
3. Telephone follow-up calls: After discharge, the
patient will receive four telephone calls taking place
one week after discharge, as well as one, three and
five months after discharge, respectively (see outline
of questions in Table 2).
Table 1 Description of the traditional rehabilitation programme (control intervention) provided at each rticipating centre at the start of the study
Centre Structure of the rehabilitation stay Interventions (leng of sessions and number of sessions pr week)








1 Three to four weeks in-patient











Gym exercises (30 m 5) Psychologist (as
needed)
Gym exercises (60 m 4)
Patient education (6 in × 1)
2 Two weeks at a day hospital
(5 + 5 days with active treatment)
Physician, PT, OT, SW Once pr
week
Pool exercises (30 m 5) PT, OT or SW
(30 min × 5)
Pool (30
min x 5)
Hand exercises (30 × 5)
Gym exercises (45 + min × 5)
3 Two weeks in-patient rehabilitation





Pool exercises (30 m 5) PT (45 min × 4) Gym exercising
(as desired)
OT (as needed)
Gym exercises with derate intensity
(30 min x 5) and/or
Nurses (as needed)
Gym exercises with intensity (30 min x 5)
Relaxation (30 min ×
Outdoor exercises ( in × 3)
4 Six days in-patient stay with main focus
on self-management (up to 16 patients
within the same diagnostic group,





None Lectures concerning eases and treatment,
physical activity, nu n, social security benefits,
pain management, s management, relaxation,
communication, ass ent of one’s own resources








Pool exercises (45 m 1)
Gym exercises (60 m 1)
Nordic walking (45 × 1)
5 Fifteen days in-patient rehabilitation
(3 + 5 + 3 days with active treatment)
Rheumatologist, physician,
PTs, OTs, SW, nurse
Twice pr
week
















































Table 1 Description of the traditional rehabilitation programme (control intervention) provided at each participating centre at the start of the study
(Continued)
6 Two weeks in- patient rehabilitation
(5 + 5 days with active treatment)
Rheumatologists, nurse, PTs, OTs,




Pool exercises (30 min × 5) PT (30 min × 5) Pool and gym
exercising
(as desired)OT (30 min × 2)
Hand exercises (30 min × 5) SW (as needed)
PT (as needed)
Activity pacing (60 min × 1) Dietary supervisor
(as needed)
Relaxation (15 min × 2)
Nordic walking (45 min × 2)
Gym exercises (45 min × 3)



















Table 2 An outline of the questions that will be asked in
the initial goal-setting conversation a few days after
admission, in the goal-setting conversation at discharge,




1 In this conversation we will try to agree on some goals for
your rehabilitation stay. These should be based on what is
important to you now and what you would like to change
in your life, and they will be used to help you navigate
during your stay and in your everyday life at home after
discharge. So, could you tell me what thoughts you have
concerning your long-term goals?
2 What would be important short-term goals to work on
during your rehabilitation stay?
Discharge
1 Let’s start with a brief look back. Is there anything you
experienced or gained during your stay that has been
particularly important to you?
2 What thoughts do you have about what should be your
long-term goals now?
3 What will be your specific short-term goals? What will
you do day by day and week by week to achieve your
long-term goals?
4 And specifically, what will you do next week?
5 And tomorrow?
First telephone follow-up
1 How are you?
2 Are there any specific challenges or issues you would like
to discuss?
3 What are your most important goals now?
4 Could you please tell me a little about your plans for
achieving those goals?
Second telephone follow-up
Same questions as in the first telephone follow-up call,
with the following additional question:
5 Are there any other issues you’d like to discuss or new
goals you’d like to pursue?
Third telephone follow-up
Same questions as in the second telephone follow-up call.
Fourth telephone follow-up
Same questions as in the second and third telephone
follow-up, with the following additional question:
6 This is the last time I'll call you. Is there anything else you
would like to add or discuss before we finish?
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interventions offered in the rehabilitation
intervention, the self-help booklet and the telephone
follow-up calls will all be based on principles derived
from cognitive behavioural therapy and MI [27,28].
Guides for how to perform the goal-setting process and
follow-up telephone calls will be developed, includingtemplates for recording the rehabilitation goals throughout
the study period.
Outcome measures
All outcome measures will be patient self-reported, and
will be collected at admission and discharge, in addition
to six and 12 months after discharge (see summary of
measures to be collected in Table 3). The local study co-
ordinator at each centre will administer the question-
naires to each participant after they have received oral
and written information about the study and signed a
written consent, and if needed, help and guidance on
how to complete the questionnaires will be offered. At
admission, the second set of questionnaires will be com-
pleted by the participant, and again, supervision will be
offered.
The data at the six- and 12-month follow up will be
collected in telephone interviews by secretaries working
at the National Resource Centre for Rehabilitation in
Rheumatology. Two weeks before each interview, the
questionnaires will be sent by post to the participant, to-
gether with a letter containing a suggested time for the
interview and a request that the participant may read
through- and complete the questionnaires on the last
day before the interview. Contact information will be
provided in the letter, and the participant will be encour-
aged to contact the secretary to make a new appoint-
ment if he/she is not available at the suggested time.
Primary outcome measure
The primary outcome in this study will be goal attain-
ment and health-related quality of life measured by the
Patient Generated Index (PGI) [42,43], which is an indi-
vidualized instrument completed in three stages: In stage
1, the respondent will be asked to list up to five areas of
life affected by his/her rheumatic condition, with an
example list of areas provided that he/she can consult
if necessary. A predefined sixth area will be listed as
“all other areas of your life affected by your rheumatic
disease”. In stage 2, the respondent will rate the areas
given in stage 1 on numeric rating scales ranging from
0–6 where 0 = “as bad as could possibly be” and 6 = “as
good as could possibly be”. In stage 3, the respondent
will distribute 10 points to indicate the relative import-
ance of each of the areas described in stage 1, with the
most points allocated to the most important areas.
A summarized index score of PGI will be generated as
follows: Each area ratings from stage 2 will be multiplied
by the points given to the area in stage 3. Thereafter, the
product of all areas will be summed up and divided by
the number of areas (normally six including the prede-
fined area). Lastly, this sum will be multiplied by 10 to
yield a PGI index score between 0 and 100, with higher
scores reflecting a better health-related quality of life.
















Health related quality of
life
Medical Outcome Study Short
Form-36 (SF-36), 0–100,
100 is good health
t1, t2,
t3, t4,
Pain Numeric rating scale: 0–10,
0 is no pain
t1, t2,
t3, t4,
Fatigue Numeric rating scale: 0–10,





Numeric rating scale: 0–10,
0 is no disease activity
t1, t2,
t3, t4,
Motivation for change Numeric rating scale: 0–10,
0 is no motivation
t1, t2,
t3, t4,
Self efficacy pain The Arthritis Self-Efficacy
Scale (ASES) for pain, 1–5,
1 is low self-efficacy
t1, t2,
t3, t4,
Self efficacy symptoms The Arthritis Self-Efficacy Scale
(ASES) for symptoms, 1–5,




Utility SF6D utility index, 0.29–1.00,
1.00 is full health
t1, t2,
t3, t4,
Sick leave and absence
from work past six
months
Number of days t3, t4,
Health care utilisation
past six months
Number of visits and/or
hospital stays
t3, t4,





Type and costs of equipment
purchased
t3, t4,
Paid and unpaid help
past six months
Costs and number of days
and hours,
t3, t4,
Costs related to the
rehabilitation stay
Costs pr day at each rehabilitation







Marital status Living alone or not t1
Employment status Working full time/working part
time/not working/student/working
full time in the home/unemployed
or seeking work/age retired/
disability pension/sick leave
t1
Level of education t1
Table 3 Summary of measures to be collected (Continued)
7-10 years of education, 10–12 years
of education, more than 12 years of
education
Comorbidity Presence of 16 diseases/health
problems (yes/no)
t1
Level of exercising 3 times pr week, 1–2 times pr week,
1–2 times pr month, not on a
regular basis, or I can not exercise





3 times pr week, 1–2 times pr week,
1–2 times pr month, not on a
regular basis, or I can not exercise




Physical activity International Physical Activity
Questionnaire-Short Form, IPAQ,
mean minutes/week of, vigorous-
intensity activity, moderate-intensity
activity, walking, and sitting
t1, t2,
t3, t4
Illness perception Rheumatic Disease Illness
Perception Questionnaire, 1 to 5, 1
is “not at all”
t1, t2,
t3, t4
t1 = admission to rehabilitation, t2 = discharge from rehabilitation, t3 = six
months after rehabilitation, t4 = twelve months after rehabilitation.
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will be asked to score the same five areas that they listed
in stage 1 at baseline.
In this study, the baseline PGI areas will also serve as
a basis for developing individual rehabilitation goals for
patients in the intervention group and for evaluating
goal attainment.
The psychometric properties of the Norwegian version
of the PGI has recently been tested with good results in
patients with rheumatic diseases undergoing rehabilita-
tion [39].Secondary outcomes
A number of secondary measures will be included (see
summary of measures to be collected in Table 3), and
11-point numeric rating scales (NRS) will be used to ob-
tain self-reported pain, fatigue, global assessment of dis-
ease activity and motivation for change. A health-related
quality of life will be measured by use of the Medical
Outcome Study Short Form-36 (SF-36) [44], which is a
widely used generic health measure. The SF-36 has eight
subscales (physical functioning, role limitations due to
physical problems, bodily pain, general health perceptions,
vitality, social functioning, mental health, and role limita-
tion due to emotional problems) that all contribute to two
higher order health scales, the Physical Component Sum-
mary (PCS) and the Mental Component Summary (MCS)
scores [44]. The Norwegian version of the SF-36 performs
well in patients with rheumatoid arthritis [45], and has been
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rehabilitation in people with rheumatic diseases [4,46].
Self-efficacy is concerned with people’s judgments of
their capabilities to execute given levels of performance
and to exercise control over events [47], and will be
measured using the sub-scales for pain and symptoms
from the Arthritis Self-Efficacy Scale (ASES) [48]. The
self-efficacy pain score is the mean of the statements for
each sub-scale, and is expressed as a value between 1
and 5, with a score of 1 representing the lowest possible
level of self-efficacy (Garrat A, Løchting I, Klokkerud M,
Hagen KB: The Arthritis Self-Efficacy Scales (ASES) with
five-point descriptive scales: results from a patient panel
and survey of three rehabilitation centres, in preparation).
Cost-effectiveness
The direct and indirect costs in the study period will be
self-reported at six and 12 months as the number of days
of sick leave and absence from paid work over the past six
months, the number of visits to a given list of health pro-
viders during the past six months and the number of
hospital visits or stays over the past six months. The partici-
pants will also report on any medication taken for their
rheumatic disease, medical or technical equipment pur-
chased during the past six months and the number of days
or hours they needed paid or unpaid help from others, in-
cluding any costs related to paid help.
Additionally, data on health-care resource allocation
and costs related to the rehabilitation stay will be col-
lected at all centres. This will include recordings of the
time used on the goal-setting conversations at admission
and discharge, on the four follow-up calls, and on train-
ing of the involved personnel.
An important way of assessing the effects of treatment in
health economic evaluations is the use of utility indexes,
and in this study we will use the SF6D utility index as a util-
ity measure in the cost-effectiveness analyses. SF6D is com-
prised of 11 items from the SF-36 [44] that are transformed
into a continuous outcome scored on a 0.29–1.00 scale,
with 1.00 indicating full health [49].
Other measurements
All participants will be asked to fill in a questionnaire at
inclusion containing information on socio-demographics
(age, gender, height, weight, marital status, employment
and level of education), whereas comorbidity will be
reported by asking the participant to check off the presence
of 16 diseases/health problems (yes/no).
The level of exercising and social activity will be self-
reported using two scales with the following response
categories: “3 times per week”, “1-2 times per week”, “1-
2 times per month”, “not on a regular basis” and “I can-
not exercise or be socially active due to functional
limitations”.The level of physical activity will be self-reported using
the International Physical Activity Questionnaire-Short
Form, (IPAQ-SF), which is expressed as weekly energy
expenditures determined by the expressed metabolic
equivalent task minutes per week (METs min/wk) of differ-
ent categories (sitting, walking, moderate- and vigorous-
intensity physical activity and total physical activity score)
and physical activity levels (low, moderate, and high) [50].
Illness perception will be captured by the Rheumatic Dis-
ease Illness Perception Questionnaire (RD-IPQ) [51], which
is adapted for patients with rheumatic diseases from the
original IPQ [52] and contains 11 questions about illness
perceptions over the past two weeks, with five response
alternatives ranging from “not at all” to “to a very large
extent”. An overall scale of illness perceptions will be com-
puted by adding the items representing illness conse-
quences, illness emotions and illness identity. In a last open
question, participants will be asked to write down any
thoughts concerning the cause of their rheumatic disease.
Text analyses
The content and stability of rehabilitation goals will be
explored by text analyses, and the raw text materials for
coding will be the rehabilitation goals agreed upon by the
participants and health professionals during the semi-
structured interviews shortly after admission, at discharge
and in the follow-up telephone calls (see outline of ques-
tions to be asked in the interviews in Table 2).
The biostatistician will draw a random sample of
approximately 25% of the participants from the total
sample, stratified by centre and diagnosis.
A first analysis will be carried out separately by two
independent researchers, who will read through the goal
descriptions to identify and code statements concerning pa-
tients’ long- and short-term goals. Following this, the codes
will be combined into broader categories, and finally into
overarching themes [53]. Thereafter, the analyses will be
compared and discussed until an agreement is reached, and
if applicable, taxonomies for categorizing health and func-
tioning such as the International Classification of Function,
Disability and Health (ICF) will be used as a framework for
the analyses [54]. Furthermore, goals agreed upon shortly
before discharge or in the follow-up period will be com-
pared to the initial goals to help explore whether goals are
changing over time, and if there are trends or patterns that
characterize such changes.
Statistical analyses
A biostatistician (PM) blinded for group allocation will
oversee the analyses of the data, with demographic and
clinical characteristics, as well as other baseline data,
presented to assess the baseline characteristics of the
two groups, e.g. participants who have received the trad-
itional rehabilitation programme (control group) versus
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tion group). These variables will also be compared for
both those participants who withdraw from the study
and those who remain. Parametric and non-parametric
statistical analysis models will be used depending on the
distribution of the variables.
The main comparative analyses between the two
groups will be performed using an intention-to-treat
(ITT) analysis, and descriptive statistics will be presented
for each group as the mean change (standard deviation,
95% confidence intervals) in the outcomes from baseline
to each time point. Because of the cluster nature of the
randomisation, the differences in mean change will be
compared between groups using Generalized Linear
Repeated Measures Mixed models with random effects,
adjusting for baseline values, a possible time trend and
the clustering effects of centres [37,55]. The mixed
model with random effect takes the clustering of the ob-
servations into account. In a linear mixed model with
random effects the estimates will not always follow a
F distribution. To assess the validity of the results, all
p-values will therefore be estimated via the parametric
bootstrap [56].
The main analysis for exploring factors associated with
goal attainment and improved health-related quality of
life during the first year following rehabilitation will be a
multivariate manual backward stepwise linear regression,
with the PGI sum-score at one year as the dependent
variable. The number of variables included in the ana-
lysis will be kept below 10% of the included sample size,
and will include age, gender, diagnosis, level of educa-
tion, body mass index, comorbidity, pain, fatigue, disease
activity, motivation for rehabilitation, level of exercises
and physical activity, and illness perception.
All variables will be entered into the model and the
best subsets of prognostic factors will be selected by ex-
cluding those independent variables with the smallest
contribution to the model (i.e. those with the largest
P-value). The model will be adjusted at every step for
the baseline value of the outcome and the other inde-
pendent variables.
The primary economic evaluation will take the form of
a cost-effectiveness study of the cost per extra quality
adjusted life years (QALYs), which will be calculated
using the SF6D scores at six and 12 months, respect-
ively. Differences in mean change from the baseline for
the SF6D to each time point will be weighted by the
time from the baseline using generalized linear regres-
sion modeling, adjusting for baseline levels of the SF6D
to construct QALYs and then compared between groups.
Ethical considerations
The study has been approved by the Norwegian Regional
Committee for Medical Research Ethics (REK South-East,2011/909) and by the Norwegian Social Science Data
Services (2011/6602).
The research will be carried out in compliance with
the Helsinki Declaration, personal confidentiality will be
guaranteed and declarations of voluntary participation
with detailed information on the study purposes and
processes will be signed by each participant, thereby em-
phasizing the right to withdraw from the study at any
time without any explanation.
The randomization procedure is deemed as being
ethically acceptable because all participants will receive
a rehabilitation stay comprised of either the rehabilita-
tion programme currently provided at the participating
centres or the new and potentially more effective pro-
gramme. Hence, no participants will receive an interven-
tion that is below the standard currently delivered at
each centre.
Discussion
Comprehensive rehabilitation, involving health profes-
sionals from various disciplines, is widely used as an ad-
junct to pharmacological and surgical treatment in
people with rheumatic diseases. However, the evidence
for the clinical- and cost-effectiveness of such interven-
tions is limited [57].
This paper outlines the protocol for a study where the
main aim will be to assess the effects of a structured goal
planning and tailored follow-up programme in rehabili-
tation for patients with rheumatic diseases, using a mul-
ticentre, stepped-wedge randomized controlled design.
According to Brown et al. [37], two key conditions
should be met in order to select the stepped-wedge de-
sign over a traditional parallel design: 1) There should
be a prior belief that the intervention will do more good
than harm, 2) There should be practical, logistical or fi-
nancial constraints, which means that the intervention
can only be implemented in stages. Both these condi-
tions will be met in our study. Concerning the last con-
dition, there would be a risk for contamination between
two parallel groups localized at one institution in a trad-
itional RCT because the patients in the groups might ex-
change information and experiences, thereby possibly
diminishing the differences between the two interven-
tion programmes. The stepped-wedge design protects
against such contaminant effects.
Furthermore, all participants in the trial will receive
rehabilitation, regardless of group allocation. This may
reduce the chance that participants refuse participation
for fear of ending up in a control group with an inferior
treatment. The design may therefore increase the inclu-
sion rate, and also to a large degree keep participants
blinded for group allocation.
Based on current knowledge and evidence, we will de-
velop a new rehabilitation programme that includes
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charge. The main objective of the study will be to evaluate
goal attainment, health effects and the cost-effectiveness of
this new programme compared to current traditional
rehabilitation programmes. We will seek to include a
minimum of 312 participants from six rehabilitation
centres, which will make this one of the largest rehabilita-
tion studies conducted within this patient population. The
findings will therefore constitute an important contribution
to more cost-effective- and evidence-based rehabilitation
services for people with rheumatic diseases.
In a review of the efficacy of multidisciplinary team
care programmes in rheumatoid arthritis, Vliet Vlieland
et al. advocate the use of patient-oriented outcome mea-
sures and procedures to help enhance the role of the pa-
tient in the team care process and communication
among health professionals [58]. The primary outcome
in this study will be the Patient Generated Index (PGI),
which is a patient-specific measure of a health-related
quality of life that allows each patient to choose and rate
the domains that he/she consider important.
Because the PGI captures the aspects of life that are
of direct concern to the individual, the “noise” that is
present in standardized instruments will be reduced,
which in theory will have the potential to make it more
responsive to capture the effects of rehabilitation [43]. In
addition, the described domains may be used as a basis
for discussing long- and short term rehabilitation goals,
thus enhancing communication and an active role for
the patient in the rehabilitation process.
A possible limitation in the PGI is that participants
will select and score those areas of life that are experi-
enced as problematic at baseline. The scores may
therefore be prone to regression to the mean. As this
probably will occur in both groups, it will, however,
not affect the effect estimate, calculated as the differ-
ences between groups.
In this trial, we will also use the SF-36 as a standardised
generic measure of health related quality of life. The com-
bination of a patient-specific measure and a questionnaire
with standardised items may ensure that different of aspects
of health related quality of life are captured, and will also
allow for comparison of populations and results across
studies.
Regarding scientific benefits, the multicentre design will
ensure that the new programme will be implemented in
various settings, which enhances the generalizability of the
results. Lastly, the study may increase the knowledge of
how the structure, content and follow-up of rehabilitation
stays can contribute in optimizing the effect of such stays.
If proven effective, the programme may also be applied
within other fields of rehabilitation, as well as in less
complex interventions directed at lifestyle changes and
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